间质性肺异常的血浆蛋白质组学特征
基于AGES-Reykjavik队列(N=5,259)发现与间质性肺异常(ILA)相关的血液蛋白,并在COPDGene队列(N=4,899)中重复验证。研究鉴定出SFTPB、SCGB3A1和WFDC2等与ILA及进展显著相关的蛋白,并构建了预测性能良好的机器学习模型。
要点
- SFTPB、SCGB3A1和WFDC2与ILA关联最强并在两个队列中重复验证。
- SFTPB浓度与MUC5B启动子多态性rs35705950相关。
- 多变量模型预测ILA及进展的AUC分别为0.880、0.826和0.824。
核心结论
- 发现多个与ILA、ILA进展及遗传风险因素相关的新血液蛋白,并构建了预测潜力良好的机器学习模型。
- 部分蛋白可作为早期纤维化肺病的潜在标志物。
研究设计与样本
- 研究使用两个前瞻性队列:AGES-Reykjavik(N=5,259)用于生物标志物发现,COPDGene(N=4,899)用于重复验证。
- 使用DNA适配体测量血液蛋白,靶向超过4,700种蛋白分析物。
- 采用回归模型评估蛋白与ILA、ILA进展及遗传风险因素的关联。
- 应用Adaptive LASSO模型对 bootstrap 样本数据进行分析,以发现预测ILA及其进展的蛋白集。
主要发现
- 在AGES-Reykjavik中,SFTPB与ILA的OR为3.71(95%CI 3.20-4.30;P=4.28×10^-67),SCGB3A1的OR为2.43(95%CI 2.13-2.77;P=8.01×10^-40),WFDC2的OR为2.42(95%CI 2.11-2.78;P=4.01×10^-36),并在COPDGene中重复验证。
- 在AGES-Reykjavik中,SFTPB浓度与rs35705950 MUC5B启动子多态性相关。
- 在AGES-Reykjavik中,SFTPB和WFDC2与ILA进展的关联最强。
- AGES-Reykjavik中ILA模型、COPDGene中ILA模型及AGES-Reykjavik中ILA进展模型的验证AUC分别为0.880、0.826和0.824。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Knowledge on biomarkers of interstitial lung disease is incomplete. Interstitial lung abnormalities (ILAs) are radiologic changes that may present in its early stages. Objectives: To uncover blood proteins associated with ILAs using large-scale proteomics methods. Methods: Data from two prospective cohort studies, the AGES-Reykjavik (Age, Gene/Environment Susceptibility-Reykjavik) study (N = 5,259) for biomarker discovery and the COPDGene (Genetic Epidemiology of COPD) study (N = 4,899) for replication, were used. Blood proteins were measured using DNA aptamers, targeting more than 4,700 protein analytes. The association of proteins with ILAs and ILA progression was assessed with regression modeling, as were associations with genetic risk factors. Adaptive Least Absolute Shrinkage and Selection Operator models were applied to bootstrap data samples to discover sets of proteins predictive of ILAs and their progression. Measurements and Main Results: Of 287 associations, SFTPB (surfactant protein B) (odds ratio [OR], 3.71 [95% confidence interval (CI), 3.20-4.30]; P = 4.28 × 10-67), SCGB3A1 (Secretoglobin family 3A member 1) (OR, 2.43 [95% CI, 2.13-2.77]; P = 8.01 × 10-40), and WFDC2 (WAP four-disulfide core domain protein 2) (OR, 2.42 [95% CI, 2.11-2.78]; P = 4.01 × 10-36) were most significantly associated with ILA in AGES-Reykjavik and were replicated in COPDGene. In AGES-Reykjavik, concentrations of SFTPB were associated with the rs35705950 MUC5B (mucin 5B) promoter polymorphism, and SFTPB and WFDC2 had the strongest associations with ILA progression. Multivariate models of ILAs in AGES-Reykjavik, ILAs in COPDGene, and ILA progression in AGES-Reykjavik had validated areas under the receiver operating characteristic curve of 0.880, 0.826, and 0.824, respectively. Conclusions: Novel, replicated associations of ILA, its progression, and genetic risk factors with numerous blood proteins are demonstrated as well as machine-learning-based models with favorable predictive potential. Several proteins are revealed as potential markers of early fibrotic lung disease.
引用
- Axelsson GT, Gudmundsson G, Pratte KA, et al. The Proteomic Profile of Interstitial Lung Abnormalities. Am J Respir Crit Care Med. 2022. PMID: 35438610. doi:10.1164/rccm.202110-2296OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。